NRx Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

RADNOR, Pa., Sept. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that Stephen Willard, J.D., Chief Executive Officer and Dr....

Related Keywords

Israel ,New York ,United States ,Stephen Willard ,Jonathan Javitt ,Nasdaq ,Sagient Research Systems ,Nrxp Nrx Pharmaceuticals ,Alvogen Pharmaceuticals ,Nrx Pharmaceuticals ,Nrx Pharmaceuticals Inc ,Lotte New York Palace Hotel ,Source Nrx Pharmaceuticals Inc ,Hc Wainwright Co ,Chief Executive Officer ,Chief Scientist ,Annual Global Investment ,New York City ,Fast Track Designation ,Breakthrough Therapy Designation ,Special Protocol Agreement ,Biomarker Letter ,Markets ,